NFκB plays a pivotal role in the pathogenesis of tissue injury in inflammatory and autoimmune hepatic diseases, the progression to fibrosis and ultimately the development of hepatocellular carcinoma (HCC), thus it may represent a target for the prevention or treatment of these conditions22. Here, NFKB1 is linked to hepatocellular carcinoma.